BRPI1010803A2 - "resposta imune aumentada na espécie aviária" - Google Patents

"resposta imune aumentada na espécie aviária"

Info

Publication number: BRPI1010803A2
Authority: BR; Brazil
Prior art keywords: immune response; avian species; increased immune; increased; avian
Prior art date: 2009-05-14

Application number

BRPI1010803-3A

Other languages

English (en)

Inventor

Abraham Albert

Original Assignee

Bayer Animal Health Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-05-14

Filing date

2010-05-07

Publication date

2018-06-12

2010-05-07 Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh

2018-06-12 Publication of BRPI1010803A2 publication Critical patent/BRPI1010803A2/pt

Links

241000271566 Aves Species 0.000 title 1
230000028993 immune response Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Immunology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Hematology (AREA)
Pulmonology (AREA)
Biotechnology (AREA)
Diabetes (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Fodder In General (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

BRPI1010803-3A 2009-05-14 2010-05-07 "resposta imune aumentada na espécie aviária" BRPI1010803A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US17809909P	2009-05-14	2009-05-14
US61/178.099		2009-05-14
PCT/EP2010/002809 WO2010130374A1 (en)	2009-05-14	2010-05-07	Enhanced immune response in avian species

Publications (1)

Publication Number	Publication Date
BRPI1010803A2 true BRPI1010803A2 (pt)	2018-06-12

Family

ID=42357738

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1010803-3A BRPI1010803A2 (pt)	2009-05-14	2010-05-07	"resposta imune aumentada na espécie aviária"

Country Status (34)

Country	Link
US (1)	US20120064151A1 (pt)
EP (2)	EP2429581B1 (pt)
JP (1)	JP5679589B2 (pt)
KR (2)	KR101966989B1 (pt)
CN (2)	CN104906573A (pt)
AR (1)	AR076767A1 (pt)
AU (1)	AU2010246652B2 (pt)
BR (1)	BRPI1010803A2 (pt)
CA (1)	CA2761736C (pt)
CL (1)	CL2011002808A1 (pt)
CO (1)	CO6460752A2 (pt)
CR (1)	CR20110595A (pt)
DK (2)	DK2992899T3 (pt)
EC (1)	ECSP11011448A (pt)
ES (2)	ES2550181T3 (pt)
HR (2)	HRP20151117T1 (pt)
HU (2)	HUE051005T2 (pt)
IL (1)	IL215900A (pt)
LT (1)	LT2992899T (pt)
MX (1)	MX336019B (pt)
MY (1)	MY162561A (pt)
NI (1)	NI201100196A (pt)
NZ (1)	NZ596366A (pt)
PE (1)	PE20120903A1 (pt)
PL (2)	PL2429581T3 (pt)
PT (2)	PT2992899T (pt)
RU (1)	RU2570732C9 (pt)
SI (2)	SI2992899T1 (pt)
SV (1)	SV2011004056A (pt)
TW (1)	TWI555846B (pt)
UA (1)	UA106076C2 (pt)
UY (1)	UY32634A (pt)
WO (1)	WO2010130374A1 (pt)
ZA (1)	ZA201107827B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8945590B2 (en) *	2008-03-25	2015-02-03	Juvaris Biotherapeutics, Inc.	Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC)
PL2654785T3 (pl) *	2010-12-22	2019-09-30	Bayer Intellectual Property Gmbh	Wzmocniona odpowiedź immunologiczna u gatunków wołowatych
JO3733B1 (ar)	2011-04-05	2021-01-31	Bayer Ip Gmbh	استخدام 3,2-دايهيدروايميدازو[1, 2 -c]كوينازولينات مستبدلة
CN103721253B (zh) *	2014-01-02	2015-06-10	青岛易邦生物工程有限公司	一种禽脑脊髓炎和鸡痘二联活疫苗
EP3110940A1 (en) *	2014-02-28	2017-01-04	Bayer Animal Health GmbH	Immunostimulatory plasmids
US9814769B2 (en)	2014-09-30	2017-11-14	Qatar University	Vaccines against pathogenic Escherichia coli and methods of using the same
JP2018518511A (ja) *	2015-06-26	2018-07-12	バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒＡｎｉｍａｌＨｅａｌｔｈＧｍｂｈ	細胞質ｄｎａ監視分子の調節方法
US11439703B2 (en) *	2015-07-31	2022-09-13	ELANCO US, Inc.	Enhanced immune response in porcine species
KR20180035860A (ko) *	2015-07-31	2018-04-06	바이엘 애니멀 헬스 게엠베하	수생 종에서의 향상된 면역 반응
US10933131B2 (en)	2016-07-26	2021-03-02	Bayer Animal Health Gmbh	Increased fertility in bovine species
KR20200099556A (ko)	2017-12-15	2020-08-24	바이엘 애니멀 헬스 게엠베하	면역자극성 조성물
CN114467855A (zh) *	2022-01-14	2022-05-13	广东海大集团股份有限公司	一种多病因气囊炎雏鸡模型的构建方法及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3854480A (en)	1969-04-01	1974-12-17	Alza Corp	Drug-delivery system
US4675189A (en)	1980-11-18	1987-06-23	Syntex (U.S.A.) Inc.	Microencapsulation of water soluble active polypeptides
US4458630A (en) *	1982-06-22	1984-07-10	The United States Of America As Represented By The Secretary Of Agriculture	Disease control in avian species by embryonal vaccination
US4452775A (en)	1982-12-03	1984-06-05	Syntex (U.S.A.) Inc.	Cholesterol matrix delivery system for sustained release of macromolecules
US5075109A (en)	1986-10-24	1991-12-24	Southern Research Institute	Method of potentiating an immune response
US5133974A (en)	1989-05-05	1992-07-28	Kv Pharmaceutical Company	Extended release pharmaceutical formulations
US5407686A (en)	1991-11-27	1995-04-18	Sidmak Laboratories, Inc.	Sustained release composition for oral administration of active ingredient
US5427791A (en)	1992-08-05	1995-06-27	Regents Of The University Of Minnesota	Embryonal vaccine against Newcastle disease
US5736152A (en)	1995-10-27	1998-04-07	Atrix Laboratories, Inc.	Non-polymeric sustained release delivery system
US6048535A (en)	1997-06-12	2000-04-11	Regents Of The University Of Minnesota	Multivalent in ovo avian vaccine
US6693086B1 (en) *	1998-06-25	2004-02-17	National Jewish Medical And Research Center	Systemic immune activation method using nucleic acid-lipid complexes
JP4800485B2 (ja) *	1999-03-26	2011-10-26	バイカルインコーポレイテッド	ポリヌクレオチドベースのワクチンに対する免疫応答を増強するためのアジュバント組成物および方法
EP1246848A1 (en) *	1999-12-27	2002-10-09	University Of Manitoba	GENETIC VACCINES FOR THE PRODUCTION OF CHICKEN EGG-YOLK ANTIBODIES AGAINST ENTEROTOXIGENIC i ESCHERICHIA COLI /i AND OTHER PATHOGENS
US20050181035A1 (en) *	2004-02-17	2005-08-18	Dow Steven W.	Systemic immune activation method using non CpG nucleic acids
US8945590B2 (en) *	2008-03-25	2015-02-03	Juvaris Biotherapeutics, Inc.	Enhancement of an immune response by administration of a cationic lipid-DNA complex (CLDC)

2010
- 2010-05-07 ES ES10720350.7T patent/ES2550181T3/es active Active
- 2010-05-07 UA UAA201114824A patent/UA106076C2/uk unknown
- 2010-05-07 EP EP10720350.7A patent/EP2429581B1/en not_active Not-in-force
- 2010-05-07 DK DK15178476.6T patent/DK2992899T3/da active
- 2010-05-07 KR KR1020117029865A patent/KR101966989B1/ko not_active Expired - Fee Related
- 2010-05-07 NZ NZ596366A patent/NZ596366A/en not_active IP Right Cessation
- 2010-05-07 PT PT151784766T patent/PT2992899T/pt unknown
- 2010-05-07 US US13/320,289 patent/US20120064151A1/en not_active Abandoned
- 2010-05-07 LT LTEP15178476.6T patent/LT2992899T/lt unknown
- 2010-05-07 CN CN201510317838.8A patent/CN104906573A/zh active Pending
- 2010-05-07 HU HUE15178476A patent/HUE051005T2/hu unknown
- 2010-05-07 KR KR1020177024103A patent/KR20170102379A/ko not_active Ceased
- 2010-05-07 PE PE2011001938A patent/PE20120903A1/es not_active Application Discontinuation
- 2010-05-07 HR HRP20151117TT patent/HRP20151117T1/hr unknown
- 2010-05-07 SI SI201032031T patent/SI2992899T1/sl unknown
- 2010-05-07 PT PT107203507T patent/PT2429581E/pt unknown
- 2010-05-07 WO PCT/EP2010/002809 patent/WO2010130374A1/en not_active Ceased
- 2010-05-07 BR BRPI1010803-3A patent/BRPI1010803A2/pt not_active Application Discontinuation
- 2010-05-07 PL PL10720350T patent/PL2429581T3/pl unknown
- 2010-05-07 MX MX2011011931A patent/MX336019B/es unknown
- 2010-05-07 HU HUE10720350A patent/HUE025765T2/en unknown
- 2010-05-07 ES ES15178476T patent/ES2808827T3/es active Active
- 2010-05-07 JP JP2012510144A patent/JP5679589B2/ja not_active Expired - Fee Related
- 2010-05-07 AU AU2010246652A patent/AU2010246652B2/en active Active
- 2010-05-07 SI SI201031045T patent/SI2429581T1/sl unknown
- 2010-05-07 MY MYPI2011005467A patent/MY162561A/en unknown
- 2010-05-07 EP EP15178476.6A patent/EP2992899B1/en active Active
- 2010-05-07 RU RU2011150529/15A patent/RU2570732C9/ru active
- 2010-05-07 PL PL15178476T patent/PL2992899T3/pl unknown
- 2010-05-07 CN CN201080021073.9A patent/CN102427827B/zh active Active
- 2010-05-07 DK DK10720350.7T patent/DK2429581T3/en active
- 2010-05-07 CA CA2761736A patent/CA2761736C/en active Active
- 2010-05-12 TW TW099115052A patent/TWI555846B/zh not_active IP Right Cessation
- 2010-05-12 UY UY0001032634A patent/UY32634A/es not_active Application Discontinuation
- 2010-05-12 AR ARP100101647A patent/AR076767A1/es unknown
2011
- 2011-10-25 IL IL215900A patent/IL215900A/en active IP Right Grant
- 2011-10-26 ZA ZA2011/07827A patent/ZA201107827B/en unknown
- 2011-11-10 CL CL2011002808A patent/CL2011002808A1/es unknown
- 2011-11-10 SV SV2011004056A patent/SV2011004056A/es unknown
- 2011-11-10 EC EC2011011448A patent/ECSP11011448A/es unknown
- 2011-11-11 CO CO11153951A patent/CO6460752A2/es not_active Application Discontinuation
- 2011-11-11 CR CR20110595A patent/CR20110595A/es unknown
- 2011-11-11 NI NI201100196A patent/NI201100196A/es unknown
2020
- 2020-09-29 HR HRP20201554TT patent/HRP20201554T1/hr unknown

Also Published As

Publication number	Publication date
PT2992899T (pt)	2020-09-21
CL2011002808A1 (es)	2012-07-13
RU2570732C9 (ru)	2016-09-10
SI2992899T1 (sl)	2020-10-30
HRP20201554T1 (hr)	2020-12-11
HUE025765T2 (en)	2016-05-30
EP2429581A1 (en)	2012-03-21
HUE051005T2 (hu)	2021-01-28
ZA201107827B (en)	2012-12-27
RU2570732C2 (ru)	2015-12-10
AR076767A1 (es)	2011-07-06
TW201043698A (en)	2010-12-16
PT2429581E (pt)	2015-11-02
CN102427827A (zh)	2012-04-25
KR20170102379A (ko)	2017-09-08
RU2011150529A (ru)	2013-06-20
ECSP11011448A (es)	2011-12-30
EP2992899A1 (en)	2016-03-09
WO2010130374A1 (en)	2010-11-18
CN102427827B (zh)	2015-07-22
CR20110595A (es)	2012-03-09
DK2992899T3 (da)	2020-09-14
KR101966989B1 (ko)	2019-04-08
JP5679589B2 (ja)	2015-03-04
TWI555846B (zh)	2016-11-01
CA2761736A1 (en)	2010-11-18
NI201100196A (es)	2012-06-06
CA2761736C (en)	2017-09-26
MX2011011931A (es)	2011-12-06
EP2429581B1 (en)	2015-08-05
KR20120027345A (ko)	2012-03-21
MX336019B (es)	2016-01-06
LT2992899T (lt)	2020-10-26
PL2992899T3 (pl)	2021-04-06
NZ596366A (en)	2013-12-20
PE20120903A1 (es)	2012-08-01
ES2550181T3 (es)	2015-11-05
IL215900A0 (en)	2012-01-31
PL2429581T3 (pl)	2016-01-29
JP2012526734A (ja)	2012-11-01
CN104906573A (zh)	2015-09-16
SV2011004056A (es)	2012-03-14
SI2429581T1 (sl)	2015-11-30
MY162561A (en)	2017-06-30
IL215900A (en)	2017-07-31
EP2992899B1 (en)	2020-07-01
HRP20151117T1 (hr)	2015-11-20
HK1168032A1 (zh)	2012-12-21
AU2010246652A1 (en)	2011-11-17
UY32634A (es)	2010-12-31
DK2429581T3 (en)	2015-11-09
ES2808827T3 (es)	2021-03-02
CO6460752A2 (es)	2012-06-15
AU2010246652B2 (en)	2014-10-02
UA106076C2 (uk)	2014-07-25
US20120064151A1 (en)	2012-03-15

Legal Events

Date	Code	Title	Description
2018-06-26	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-07-17	B25A	Requested transfer of rights approved	Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)
2019-10-01	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2021-07-27	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2021-08-24	B350	Update of information on the portal [chapter 15.35 patent gazette]
2021-12-07	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2022-04-26	B09B	Patent application refused [chapter 9.2 patent gazette]
2023-10-03	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

Publication	Publication Date	Title
BRPI1010803A2 (pt)	2018-06-12	"resposta imune aumentada na espécie aviária"
HUE031343T2 (hu)	2017-07-28	Immunitásindukáló ágens
EP2487146A4 (en)	2014-03-19	hONEYCOMB STRUCTURE
BR112013016231A2 (pt)	2016-09-27	resposta imune aumentada em espécies bovinas
HUE036081T2 (hu)	2018-06-28	Mirac proteinek
SI2126093T1 (sl)	2013-01-31	IzboljĹˇanje priprave proteinov
HUE037163T2 (hu)	2018-08-28	Hemoglobin készítmények
EP2929045A4 (en)	2016-06-01	PROTEIN EXPRESSION REINFORCING POLYPEPTIDES
HRP20170138T1 (hr)	2017-04-07	Ponovno dobivanje proteina
BRPI1013030A2 (pt)	2016-04-05	"aquecedores"
BR112012004402A2 (pt)	2016-11-16	glicosilação de proteína
EP2419414A4 (en)	2013-12-04	MEANS FOR ACTIVATING PROTEIN PHOSPHATASE 2A
DK3066918T3 (da)	2019-09-30	Optisk understøttet nyttedyrslokaliseringsindretning
BRPI0915072A2 (pt)	2018-02-06	composição contendo uma fração de proteína para defender o sistema imune no idoso
BR112013010223A2 (pt)	2017-05-23	"piranosidade temperatura- estável"
BRPI1013017A2 (pt)	2016-03-29	"17beta-alquil-17alfa-óxi-estratrienos"
FR2934783B3 (fr)	2010-12-10	Tire-lait
BRPI0822616A2 (pt)	2015-06-23	"elevador transportador de água"
EP2195338A4 (en)	2010-11-03	N-TERMINAL MODIFIED INTERFERON ALPHA
TH101661B (th)	2010-05-31	ซิปรูด
FR2940753B3 (fr)	2010-12-31	L'eco-sapin
ES1071507Y (es)	2010-06-01	Pañuelo-bragueta de calzoncillo o pantalon
FIU20090290U0 (fi)	2009-08-12	Valaistuslaitteisto
ATE515465T1 (de)	2011-07-15	Sortieranlage
FIU20090048U0 (fi)	2009-02-04	Kausiasuste